BlackRock Inc. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$24,479,000
-1.6%
7,199,683
+8.9%
0.00%0.0%
Q2 2018$24,866,000
+0.0%
6,613,445
+8.8%
0.00%0.0%
Q1 2018$24,863,000
-12.3%
6,078,614
-0.3%
0.00%0.0%
Q4 2017$28,356,000
-33.3%
6,097,948
+1.9%
0.00%
-50.0%
Q3 2017$42,498,000
+8.7%
5,985,567
+10.7%
0.00%0.0%
Q2 2017$39,085,000
+17.2%
5,405,826
-0.2%
0.00%0.0%
Q1 2017$33,359,000
+83297.5%
5,415,331
+80281.9%
0.00%
Q4 2016$40,000
-4.8%
6,737
-15.6%
0.00%
Q3 2016$42,000
-20.8%
7,9830.0%0.00%
Q2 2016$53,000
+89.3%
7,983
+30.4%
0.00%
Q1 2016$28,000
+133.3%
6,123
+157.6%
0.00%
Q4 2015$12,000
+50.0%
2,3770.0%0.00%
Q3 2015$8,000
-66.7%
2,3770.0%0.00%
Q2 2015$24,000
-20.0%
2,3770.0%0.00%
Q1 2015$30,000
-11.8%
2,3770.0%0.00%
Q4 2014$34,000
+3.0%
2,3770.0%0.00%
Q3 2014$33,000
-8.3%
2,3770.0%0.00%
Q2 2014$36,000
-29.4%
2,377
-21.6%
0.00%
Q1 2014$51,000
+88.9%
3,032
+43.7%
0.00%
Q4 2013$27,000
+28.6%
2,1100.0%0.00%
Q3 2013$21,000
+31.2%
2,1100.0%0.00%
Q2 2013$16,0002,1100.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders